Intelligent Bio Solutions ships Intelligent Fingerprinting Drug Screening Readers with Syrma Johari MedTech: New York Saturday, February 28, 2026, 16:00 Hrs [IST] Intelligent Bio ...

Detailed price information for Intelligent Bio Solutions Inc (INBS-Q) from The Globe and Mail including charting and trades.

Successful delivery in partnership with Syrma Johari validates manufacturing scale, strengthens commercial readiness, and supports planned U.S. market entry in 2026 ...

Bouygues UK’s leadership emphasized the joint nature of the relationship with INBS, distinguishing it as a collaborative partnership rather than a conventional supplier-customer arrangement. Bouygues ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Gross profit margins for first half fiscal 2026 increased 10% year-over-year to 49%, reflecting improved operational efficiency Current assets balance of $12.17 million as of December 31, 2025, ...

GAITHERSBURG, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions, Inc. (NYSE: EBS) announced it made a voluntary prepayment of $100 million under its outstanding term loan facility in ...

NEW YORK, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing ...

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining more than 100 points on Friday. The Dow traded up 0.27% to 48,195.28 while the NASDAQ fell 0.14% to 23,209.54. The S&P ...

Intelligent Bio said it will raise $10 million through a private placement, which weighed on shares following the announcement. The deal includes 2.298 million shares, Series K-1 warrants to purchase ...